LifeMD (LFMD)
(Delayed Data from NSDQ)
$11.95 USD
+1.13 (10.44%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $11.99 +0.04 (0.33%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum B VGM
Balance Sheet
Fiscal Year End for LifeMD, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 33 | 4 | 41 | 9 | 1 |
Receivables | 5 | 3 | 1 | 1 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 3 | 4 | 2 | 1 | 1 |
Other Current Assets | 1 | 1 | 1 | 1 | 1 |
Total Current Assets | 43 | 11 | 45 | 12 | 3 |
Net Property & Equipment | 12 | 9 | 3 | 0 | 0 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 3 | 4 | 0 | 0 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 0 |
Total Assets | 58 | 26 | 50 | 13 | 3 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 3 | 0 | 1 | 1 |
Accounts Payable | 11 | 10 | 21 | 12 | 3 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 14 | 12 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 9 | 6 | 2 | 1 | 0 |
Total Current Liabilities | 35 | 31 | 23 | 13 | 4 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 18 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 1 | 0 | 0 | 1 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 53 | 33 | 24 | 14 | 5 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 5 | 4 | 4 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 1 |
Capital Surplus | 218 | 179 | 165 | 78 | 15 |
Retained Earnings | -214 | -191 | -142 | -80 | -17 |
Other Equity | 2 | 0 | -1 | -2 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 6 | -7 | 26 | -1 | -1 |
Total Liabilities & Shareholder's Equity | 58 | 26 | 50 | 13 | 3 |
Total Common Equity | 6 | -12 | 22 | -4 | -1 |
Shares Outstanding | 37.90 | 31.40 | 30.50 | 23.10 | 10.60 |
Book Value Per Share | 0.15 | -0.38 | 0.71 | -0.19 | -0.11 |
Fiscal Year End for LifeMD, Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 33 | 15 | 12 | 12 |
Receivables | NA | 5 | 4 | 4 | 3 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 3 | 4 | 4 | 3 |
Other Current Assets | NA | 1 | 1 | 1 | 1 |
Total Current Assets | NA | 43 | 25 | 20 | 19 |
Net Property & Equipment | NA | 12 | 12 | 11 | 10 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 3 | 3 | 4 | 4 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 58 | 41 | 35 | 34 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 1 | 2 |
Accounts Payable | NA | 11 | 10 | 10 | 7 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 14 | 15 | 15 | 12 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 9 | 6 | 6 | 6 |
Total Current Liabilities | NA | 35 | 33 | 32 | 27 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 18 | 19 | 14 | 13 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 53 | 52 | 46 | 41 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 5 | 5 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 218 | 197 | 187 | 183 |
Retained Earnings | NA | -214 | -210 | -203 | -195 |
Other Equity | NA | 2 | 2 | 1 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 6 | -11 | -10 | -7 |
Total Liabilities & Shareholder's Equity | NA | 58 | 41 | 35 | 34 |
Total Common Equity | 0 | 6 | -11 | -15 | -12 |
Shares Outstanding | 40.30 | 37.90 | 36.00 | 32.40 | 32.50 |
Book Value Per Share | 0.00 | 0.15 | -0.31 | -0.47 | -0.37 |